Document is current
Any future updates will be listed below
-
Authors
Perriot, Sylvain https://orcid.org/0000-0002-0337-3262
Jones, Samuel https://orcid.org/0009-0003-2391-7997
Genolet, Raphaël https://orcid.org/0000-0001-9335-3945
Mathias, Amandine https://orcid.org/0009-0005-3604-5096
Lindsay, Helen
Bobisse, Sara
Di Liberto, Giovanni https://orcid.org/0000-0001-6788-0215
Canales, Mathieu
Queiroz, Lise
Sauvage, Christophe
Wagner, Ingrid https://orcid.org/0000-0003-4437-9799
Oberholster, Larise
Gimenez, Marie
Bégarie, Diane
Kovac, Stjepana
Desestret, Virginie
Théaudin, Marie https://orcid.org/0000-0002-3026-3595
Pot, Caroline https://orcid.org/0000-0002-1146-3129
Wiendl, Heinz https://orcid.org/0000-0003-4310-3432
Honnorat, Jérôme https://orcid.org/0000-0002-4721-5952
Merkler, Doron https://orcid.org/0000-0002-0247-2007
Gottardo, Raphaël https://orcid.org/0000-0002-3867-0232
Harari, Alexandre https://orcid.org/0000-0002-1055-2090
Du Pasquier, Renaud https://orcid.org/0000-0002-2786-3434
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030-179531)
- License Information
-
More Information
Article History
Received: 27 March 2024
Accepted: 24 August 2025
First Online: 29 September 2025
Competing interests
: S.P., S.J., A.M., H.L., G.D.L., M.C., L.Q., C.S., I.W., L.O., M.G., D.B., S.K., V.D., M.T., C.P., H.W., J.H., D.M., R.D.P. have nothing to disclose related to this work. R.Ge. has patents in technologies related to TCR repertoire analysis. S.B. and A.H. have patents in technologies related to T cell expansion and engineering for T cell therapy, none related to this work. R.Go. has received consulting income from Takeda, Sanofi, Arcellx (all payments to the institution) and declares ownership in Ozette Technologies, none related to this work.
